Summary
Quest Diagnostics Incorporated (DGX) filed an 8-K on July 23, 2019, to announce its financial results for the quarter ended June 30, 2019. This filing primarily references an attached press release (Exhibit 99.1) which contains the detailed financial information for the period. Investors should refer to this press release for specific performance metrics, revenue figures, earnings per share, and any forward-looking guidance provided by the company. The significance of this 8-K lies in its role as the official disclosure of the company's recent operational and financial performance. While the 8-K itself is a notification of the event and the attached exhibit, the press release is the primary source for understanding how Quest Diagnostics performed during the second quarter of 2019, which is crucial for assessing the company's trajectory and making informed investment decisions.
Key Highlights
- 1Quest Diagnostics filed an 8-K on July 23, 2019, to report Q2 2019 financial results.
- 2The filing incorporates by reference a press release (Exhibit 99.1) containing the detailed financial results.
- 3Investors need to consult the referenced press release for specific performance data for the quarter ended June 30, 2019.
- 4This 8-K serves as the formal SEC notification of the earnings release.
- 5No new financial statements or complex operational details are presented directly within the 8-K filing itself.